JW (Cayman) Therapeutics Co. Ltd

Biotechnology company · Shanghai, China

JW (Cayman) Therapeutics Co. Ltd is a biotechnology company headquartered in Shanghai, China. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $106 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

JW (Cayman) Therapeutics at a glance

Typebiotechnology company

HeadquartersShanghai, China

Earliest incorporation on record2017

SEC CIK1817872

What does JW (Cayman) Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $105.5 million sold (2020).

Frequently asked questions about JW (Cayman) Therapeutics

Where is JW (Cayman) Therapeutics headquartered?

JW (Cayman) Therapeutics Co. Ltd is headquartered in Shanghai, China.

What does JW (Cayman) Therapeutics do?

JW (Cayman) Therapeutics Co. Ltd is a biotechnology company.

When was JW (Cayman) Therapeutics founded?

The earliest incorporation on record for JW (Cayman) Therapeutics Co. Ltd is in 2017, according to public company registers.

Similar companies

TenNor Therapeutics (Suzhou) LtdSuzhou, Jiangsu, China
China Biologic Products Holdings, Inc.Beijing, China
Seasons Biotechnology (Taizhou) Co LtdTaizhou, Zhejiang, China
Clover Biopharmaceuticals, Ltd.Chengdu, Sichuan, China

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences